Cleartronic Inc (CLRI) Q4 2024 Earnings Report

Cleartronic Inc posted a Q4 2024 revenue of $943,038, up 70.14% year over year, with a robust gross margin of 71.0% ($669,611) and an operating loss of $261,008 (EBIT) and net loss of $296,557. Despite topline growth, the company continues to incur meaningful operating expenses (G&A and SG&A largely) that drive a negative EBITDA (-$286,218) and a negative net income with a basic EPS of -0.0012. QoQ revenue declined ~6.2%, signaling near-term压力 in sustaining sequential gains, even as the year-ago base benefited from lumpy deployments typical of a small software/services player.

The balance sheet shows a strong cash position (cash and equivalents of $849,727) and a net cash position (net debt of -$843,221) driven by modest debt and sizable cash on hand. However, liquidity metrics remain conservative with current ratio 0.80 and quick ratio 0.77, reflecting a sizable current liability base, including deferred revenue of $1,373,325 that could unwind into revenue upon delivery or service recognition. Candidly, negative shareholders’ equity (-$202,431) and a large cumulative deficit (retained earnings of -$15.44 million) underscore the need for a sustainable path to profitability and stronger balance-sheet resilience.

Management commentary is not provided in the provided transcript data, so the analysis relies on the disclosed quarterly results and ratios. In this context, CLRI appears to be at a crossroads: it generates meaningful gross profit from its ReadyOp/IP offerings but faces structural cost pressures and requires better operating leverage or revenue-recognition clarity to translate top-line growth into sustainable profitability. Investors should monitor whether management sets concrete cost-control initiatives, a recalibrated go-to-market strategy, or additional milestones around ReadyOp/ReadyMed adoption that could unlock higher gross-to-operating leverage.